Tag Archives: drug-resistant TB

XDR Becoming More Resistant: "We Will Run Out of Letters Soon"

By on .

Last week, the Global Center released a new issue brief on drug-resistant TB to mark World TB Day. Included in the brief was this interview with Dr. Sarita Shah, who recently presented new research showing that strains of extensively drug-resistant TB (XDR-TB) in Tugela Ferry, South Africa, are becoming more resistant. Tugela Ferry is ground […]

World TB Day Briefing Will Shine New Light on Epidemic

By on .

Tomorrow is World TB Day—and the halfway point for the Global Plan to Stop TB. What better time to learn about the latest TB research and the most innovative approaches to combating combat this ancient deadly epidemic? Those items will be on the agenda tomorrow, along with data about the virulent threat of drug-resistant TB, […]

Reactions to the New CSIS Report on "Smart Global Health Policy"

By on .

The Center for Strategic and International Studies yesterday unveiled  a new “must-read” report for global health advocates, “Smart Global Health Policy.” While a panel at the Congressionally-chartered Institute of Medicine, made up primarily of scientists, issued recommendations on US global health policy last year, the CSIS panel is the first to involve high-level business leaders […]

Promising New TB Drugs Put on a Fast Track

By on .

This afternoon, Dr. Mel Spigelman, president and CEO of the Global Alliance for TB Drug Development, and other leading TB advocates will join with FDA Commissioner Margaret Hamburg to launch a new initiative designed to accelerate the development and approval of life-saving new treatments for tuberculosis. There are now at least 9 promising new TB […]

New Study & Other Scary TB Stories

By on .

If ever there was a time to be getting more vigilant, not less, about combating tuberculosis, it is now, as strains of this ancient bug are becoming more virulent and better able to dodge our medical weaponry. Take this disconcerting new study from researchers at the Johns Hopkins Bloomberg School of Public Health and colleagues in China, […]

New MDR-TB Study Highlights the Promise of R&D in Fight Against Deadly Bug

By on .

In a small new study, researchers found that linezolid, an antibiotic first approved in 2000, may be an effective component in the treatment of multidrug-resistant drug-resistant tuberculosis. But as previous research of this drug has suggested, linezolid is far from a perfect cure for the global epidemic of drug-resistant TB, and the findings reinforce the […]

WHO Report: Progress Made in Treating TB, But Key Challenges Remain

By on .

An estimated 8 million tuberculosis-related deaths have been averted over the last 15 years through aggressive global efforts to combat this ancient and deadly epidemic, according to a new report released today by the World Health Organization.  The epidemiological report, which provides more up-to-date figures than usual, says there were an estimated 9.4 million new […]

New vaccine would revolutionize the fight against tuberculosis…if funding is available

By on .

How could the world dramatically lower the incidence of tuberculosis and save millions of lives?  An effective TB vaccine would revolutionize the response to TB, which kills about 5000 people each day, and eliminate the need for lengthy and often difficult drug treatment.    An effective vaccine would be of tremendous benefit all over the world, including […]

Guest Blog by Paula Akugizibwe: Don't Abandon the TB Basics for a Miracle Cure

By on .

This is a guest post written by Paula Akugizibwe, regional treatment advocacy coordinator at AIDS and Rights Alliance for Southern Africa. She wrote this in response to remarks made by Marcos Espinal, of the Stop TB Partnership, to the UN Economic and Social Council on July 6. Espinal said, in part:   “MDG 6 has […]

HIV/TB Co-infection–The Deadly Duo Take Center Stage at IAS

By on .

This post is by Center Director Christine Lubinski, reporting from the 2009 IAS conference in Cape Town. World renowned HIV/TB expert Dr. Gerry Friedland, a professor of medicine at Yale and a member of the Global Center’s Scientific Advisory Committee, opened this morning’s plenary session at the 2009 IAS conference by highlighting important operational research […]